trending Market Intelligence /marketintelligence/en/news-insights/trending/MHVNU4ub85LpztYiKssEBA2 content esgSubNav
In This List

GW Pharmaceuticals adds independent board members

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


GW Pharmaceuticals adds independent board members

GW Pharmaceuticals plc appointed Catherine Mackey, Alicia Secor and William Waldegrave as independent board members.

Mackey is the CEO of CYPrus Therapeutics Inc. and board chairman of Cour Pharmaceutical Development. Secor is the president and CEO of Juniper Pharmaceuticals Inc., while Waldegrave served as chairman of Biotechnology Growth Trust plc from 1998 to 2015.